Zobrazeno 1 - 10
of 43
pro vyhledávání: '"XiaoShuang Niu"'
Publikováno v:
Cancer Biology & Medicine, Vol 21, Iss 3, Pp 198-203 (2024)
Externí odkaz:
https://doaj.org/article/05cd077fced94d669ef2236cc0d7d5a7
Autor:
Shengzhe Jin, Hongfei Wang, Yang Li, Jingwen Yang, Beibei Li, Peishang Shi, Xiangrui Zhang, Xiaowen Zhou, Xiuman Zhou, Xiaoshuang Niu, Menghan Wu, Yahong Wu, Wenjie Zhai, Yuanming Qi, Yanfeng Gao, Wenshan Zhao
Publikováno v:
Cell Communication and Signaling, Vol 22, Iss 1, Pp 1-16 (2024)
Abstract Background Targeting the tumor microenvironment (TME) has emerged as a promising strategy in cancer treatment, particularly through the utilization of immune checkpoint blockade (ICB) agents such as PD-1/PD-L1 inhibitors. Despite partial suc
Externí odkaz:
https://doaj.org/article/e691f26caa4b41538892947c9f03fbbd
Autor:
Yuzhen Qian, Yixuan Sun, Peishang Shi, Xiuman Zhou, Qiongqiong Zhang, Qingyu Dong, Shengzhe Jin, Lu Qiu, Xiaoshuang Niu, Xiaowen Zhou, Wenshan Zhao, Yahong Wu, Wenjie Zhai, Yanfeng Gao
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 14, Iss 3, Pp 1150-1165 (2024)
Aside from antibodies, peptides show great potential as immune checkpoint inhibitors (ICIs) due to several advantages, such as better tumor penetration and lower cost. Lymphocyte-activation gene 3 (LAG-3) is an immune checkpoint which can induce T ce
Externí odkaz:
https://doaj.org/article/2ac2caa014eb4e9e8e214552da52bbd8
Autor:
Xiaoshuang Niu, Menghan Wu, Guodong Li, Xiuman Zhou, Wenpeng Cao, Wenjie Zhai, Aijun Wu, Xiaowen Zhou, Shengzhe Jin, Guanyu Chen, Yanying Li, Jiangfeng Du, Yahong Wu, Lu Qiu, Wenshan Zhao, Yanfeng Gao
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 13, Iss 11, Pp 4511-4522 (2023)
Developing new therapeutic agents for cancer immunotherapy is highly demanding due to the low response ratio of PD-1/PD-L1 blockade in cancer patients. Here, we discovered that the novel immune checkpoint VISTA is highly expressed on a variety of tum
Externí odkaz:
https://doaj.org/article/6351c959bc1240cab10ee9ff5e5547e1
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background There is limited information of radical radiotherapy (RT) on lymphoepithelial carcinoma of salivary gland (LECSG) regarding to the rarity of the disease. We conducted this retrospective study that evaluated the feasibility and eff
Externí odkaz:
https://doaj.org/article/a32f47d2dae74bc39a2879a406ae7406
Publikováno v:
Cancer Medicine, Vol 13, Iss 4, Pp n/a-n/a (2024)
Abstract Purpose Intensity‐modulated radiotherapy (IMRT) combined with concurrent chemotherapy is deemed as the mainstay treatment in locoregionally advanced nasopharyngeal carcinoma (NPC). Nevertheless, the tolerance of severe acute toxicity of co
Externí odkaz:
https://doaj.org/article/6a5d232ea95146ff913bf08316418063
Publikováno v:
Translational Oncology, Vol 39, Iss , Pp 101797- (2024)
Objectives: To investigate the efficacy and safety of nimotuzumab (NTZ) combined with concurrent chemo-radiotherapy (CCRT) in induction chemotherapy (IC) resistant locally advanced nasopharyngeal carcinoma (LANPC). Materials and methods: A single-arm
Externí odkaz:
https://doaj.org/article/575384c736934dd5af224470e51c3ef9
Autor:
Xiaowen Zhou, Jiangfeng Du, Xiuman Zhou, Xiaoshuang Niu, Wanqiong Li, Chunxia Chen, Sifan Lv, Aijun Wu, Shanshan Gou, Yixuan Sun, Wenjie Zhai, Lu Qiu, Yuanming Qi, Wenshan Zhao, Yanfeng Gao
Publikováno v:
Cell Communication and Signaling, Vol 19, Iss 1, Pp 1-13 (2021)
Abstract Background TIGIT, as a novel immune checkpoint molecule involved in T cell and NK cell anergy, could induce the immune tolerance and escape through binding with its ligand PVR. Blockade of TIGIT/PVR is considered as a promising strategy in c
Externí odkaz:
https://doaj.org/article/b4e9cf3052be46b095dda3421133f84f
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveThe improvement of the efficacy of intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer (NPC) has prolonged the survival of patients, and the incidence of the second tumor has gradually increased. Among them, second primary lung
Externí odkaz:
https://doaj.org/article/780dea7ed8ad41cca6d04b84d124c96c
Publikováno v:
Translational Oncology, Vol 14, Iss 12, Pp 101216- (2021)
Objectives: To evaluate long-term outcomes of induction chemotherapy (IC) followed by intensity-modulated radiotherapy (IMRT) and adjuvant chemotherapy (AC) in nasopharyngeal carcinoma (NPC) patients with N3 disease. Materials and methods: From Septe
Externí odkaz:
https://doaj.org/article/57dae51334564fd6a9c1ff39268899b7